🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hypertriglyceridemia
Clinical trial register · China

Hypertriglyceridemia Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19029 matching records held by the registry are in this view. Synced 20 Sep 2026, 17:51 UTC
19029
Studies in scope
all four open statuses
11774
Recruiting now
open to new participants
2008
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Shanghai 3 Luoyang 2 Bengbu 1 Guangzhou 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd1 Peking Union Medical College Hospital1 Shanghai JMT-Bio Inc.1 Arrowhead Pharmaceuticals1 Junbo Ge1
Site location
Beijing4 Shanghai3 Luoyang2 Bengbu1 Guangzhou1
All 17 locations
Target enrolment
to
8 of 19029 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute Pancreatitis
NCT07617155Hypertriglyceridemia Induced Acute Pancreatitis, Recurrent Acute Pancreatitis, Pancreatitis Relapsing, Hypertriglyceridemia
Peking Union Medical College Hospital
Phase 4
396
Beijing
2026-09
Not yet open
A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia
NCT07693777Severe Hypertriglyceridemia (sHTG), Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd.
Phase 3
480
Shanghai
2026-08-17
Recruiting
A Study of SHR-1918 In Participants With Hypertriglyceridemia
NCT07349615Hypertriglyceridemia
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 3
360
Shanghai
2026-04-01
Active, closed
RBD5044 in Chinese Participants With Hypertriglyceridemia
NCT07587788Hypertriglyceridemia
Ribotek Biopharmaceuticals (Shandong) Co., Ltd
Phase 2
40
Daqing, Harbin, Luoyang, Jingzhou, Nanyang, Yuncheng, Beijing
2026-02-28
Recruiting
a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia
NCT07140809Hypertriglyceridemia
Shanghai JMT-Bio Inc.
Phase 1/2
48
Beijing
2025-09-09
By invitation
A Trial to Evaluate the Efficacy and Safety of DR10624 in Patients With Hypertriglyceridemia and Carotid Atherosclerotic Plaque
NCT07050134Hypertriglyceridemia, Carotid Atherosclerotic Plaques
Junbo Ge
Not applicable
40
Hefei, Suzhou, Shanghai
2025-07-01
Recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
NCT06822790Hypertriglyceridemia
Arrowhead Pharmaceuticals
Phase 3
869
Bengbu, Beijing, Guangzhou, Liuzhou, Xingtai, Luoyang, Changsha, Wuhan
2025-04-09
Active, closed
Single-ascending Dose Study of Kylo-12 in Healthy Subjects
NCT06783881Hypertriglyceridemia
Kylonova (Xiamen) Biopharma co., LTD.
Phase 1
50
Chengdu
2025-03-12
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-china/condition/hypertriglyceridemia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.